Rx Medicare

Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) announced that the company has been granted a Special 510(k) clearance to update the TRU FLU package insert to include analytical sensitivity claims with two strains of 2009 H1N1 virus cultured from positive respiratory specimens. TRU FLU is a rapid test which identifies influenza A and B in human specimens.

Read More…

Related Posts

• Diagnostic Hybrids Receives FDA Emergency Use Authorization For D3 Ultra 2009 H1N1 Influenza A Virus ID Kit
• FDA Approves Additional Vaccine For 2009 H1N1 Influenza Virus
• Warnex Launches Test For Influenza A H1N1 Virus Mutation Associated With Resistance To Tamiflu(R)
• Swine Flu: NIAID Set To Launch Clinical Trials To Test 2009 H1N1 Influenza Vaccine Candidates
• Cases Of The 2009 H1N1 Influenza A Virus Confirmed In Crawford And Miami Counties
• Groups At High Risk Of H1N1 Influenza A Should Avoid Travelling To 2009 HAJJ
• CSL Biotherapies Obtains FDA Licensure For Use Of Its Thimerosal-Free Pandemic Influenza A (H1N1) 2009 Monovalent Vaccine In Children
• USDA Conducting Confirmatory Testing On Possible Detection Of 2009 Pandemic H1N1 Influenza In U.S. Swine
• Cherokee County Death Linked To 2009 H1N1 Influenza
• Mobile Death Linked To 2009 H1N1 Influenza
• Fifteen Alabama Deaths Now Linked To 2009 H1N1 Influenza
• Three Additional Alabama Deaths Linked To 2009 H1N1 Influenza
• European Medicines Agency Recommends Authorisation Of Two Vaccines For Influenza Pandemic (H1N1) 2009
• Additional Alabama Death Linked To 2009 H1N1 Influenza
• Additional Alabama Deaths Linked To 2009 H1N1 Influenza

Tags: 2009, 510k, analytical, claim, clearance, efficacy, flur, granted, h1n1, influenza, insert, meridian, package, sensitivity, special, test, virus

This entry was posted on Sunday, September 20th, 2009 at 4:09 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.